News

The CTI/KTI project “Banking of human antibody repertoires for therapeutic use” was approved and starts in June 2016. The project …

Meet MEMO through the partnering system at Bio 2016 in San Francisco. See the meeting schedule for more details.

The guardian’s recent article “Ebola treatment using antibody from survivor’s blood passes first trial” describes the therapeutic use of an …

MEMO has reached proof of concept with its rbMemoMAB™ process. First monoclonal antibody candidates could be isolated from an immunized …

Memo Therapeutics is a 2015 Swiss top 100 start-up.
Link to Top 100 list 2015.

The Swiss biotech company Memo Therapeutics AG closes a series A financing round of 2.3 million Swiss Francs to develop …

Memo Therapeutics at the ieLab
Memo Therapeutics has moved into its own lab facilities at the ieLab at the ETH …